Tag: USLV

Blue Horseshoe Stocks: VTVT Recap & More

vTv Therapeutics, Inc. VTVT

Our report yesterday morning included  a look at the VTVT chart, and establishing our interest in tracking it as a bottom play. Our timing in this really could not have been any better as the stock not only made it biggest single session move of the year, but also traded its highest volume.

VTVT ran from a low of .79 and reached as high as 1.67, a 53% intraday rip, and ended up closing at 1.19, filling a portion of the large gap which you can plainly see below. Based on the activity we’ve now witnessed, and the still-ripe look of the chart, we’re going to continue to keep a close watch over VTVT.

Van Eck Vectors Gold Miners ETF (GDX)

We also want to begin tracking a pair of options contracts in the GDX chain. Gold has been doing well and looks as if another solid day could be in the cards.

On that event, there should be some nice activity in the GDX Weekly $22.50 & $23 Calls, so we’ll be monitoring for that.


Tandem Diabetes Care, Inc. TNDM – Update

It was a week ago today that we were commenting on our coverage of TNDM in 2018. We caught this stock at a low of 2.14 earlier this year, and it has come a long way since then.

This week the stock has traded up to a high of 7.75, marking an increase of 262% since we began tracking it.

Extended Watchlist:
TEUM, ARQL, SPWR, PRPO, INPX, USLV, OAS

Blue Horseshoe Stocks: Bottom-Watch Play & More

Eastman Kodak Co. KODK – Update

It was a few weeks ago on the 12th of January that we signaled a range of puts in the Kodak options chain.  The company had seen a considerable surge in price after announcing its own unique crypto-coin, but we took a skeptical position as to its sustainability.

We highlighted the KODK 02/16 $15 & $12.50 Puts.
and wanted to come back around to it this morning to check out the gains that were made possible as the stock has predictably failed to maintain its uptrend, and instead has fallen significantly since our alert.

As a result, the $15 Puts have run from 4.70-8.80 for an 87% pop, while the $12.50’s traded from a low of 2.60 up to 6.50, a gain of 150%

Auris Medical Holding Inc. EARS

We lso want to add a quick bottom watch play in EARS to kick off the week this morning.

It’s got multiple gaps to fill to the upside and is currently considerably oversold. We’ll want to watch this stock for a potential rebound in the days and weeks ahead.

Extended Watchlist:
JAGX, MARK, USLV, BUR, GERN, XNET

Blue Horseshoe Stocks: KORS Recap & More

Michael Kors Holdings, Ltd. KORS – Options Recap

We took the opportunity to signal some KORS options yesterday in the wake of the company’s convincing earnings beat, and it was a good thing we did, because the stock had a monstrous session, running from a low of 42.71 to a high of 45.73.

That was more than enough of an intraday push to facilitate some really great gain opportunities for anyone who looked into our highlighted ideas, the KORS Weekly $41.50-43.50 Calls. Each and every contract in our specified range erupted with big time multi-bag moves on the day exceeding 1000%, which were as follows:

$41.50 Calls – Range: .31-3.97 – Max Gain: 1180%
$42 Calls – Range: .25-3.45  – Max Gain: 1280%
$42.50 Calls – Range: .20-2.65 – Max Gain: 1225%
$43 Calls – Range: .14-2.75 – Max Gain: 1864%
$43.50 Calls – Range: .13-2.25 – Max Gain: 1630%

This was certainly one of our sharpest calls and greatest plays of the entire summer so far, so cheers go out to anyone who hopped on for the ride!

Ubiquitech Software Corp. UBQU

The UBQU newsreel has been hot over the last week, wherein we learned that the company’s HempLife subsidiary was expanding its line of CBD products to include offerings for pets, and that UBQU also launched a new division that brings it into the trendy cryptocurrency space.

Along with a confluence of recent developments, we are also seeing bottom-bounce potential in the UBQU chart at the present time.The stock has essentially been getting beaten back all summer long, so we’ll want to begin watching for the possibility of a convincing rebound in the days ahead.

Extended Watchlist:
NVO, ATHM, USLV, ACHN, XTNT, NVAX, ANTH, EVRI, XXII